💨 Abstract

The U.S. has imposed a 26% tariff on imports from India, a setback to India's hopes for relief from President Trump's trade policy. The tariff, which takes effect from April 9, was based on tariff and non-tariff barriers including currency manipulation. India's pharmaceutical exports, which account for nearly a third of the country's pharmaceutical exports, were exempted.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖